THBS2 and neoplasm: The same study found TF expression to be an important driver in CRC progression by observing increased tumor growth in TF-high CRC, slower growth with TF siRNA-expressing CRC clones, and higher expression of anti-angiogenic markers TSP-1 and TSP-2 in TF-silenced tumors in mouse models.